articleTop 1% cited
Varenicline Is a Partial Agonist at α4β2 and a Full Agonist at α7 Neuronal Nicotinic Receptors
Molecular Pharmacology · 2006 · Vol. 70(3) · pp. 801–805
Nicotinic Acetylcholine Receptors StudyReceptor Mechanisms and SignalingInsect and Pesticide ResearchVareniclinePartial agonistCytisineAgonistPharmacologyNicotinic agonistChemistryReceptorAcetylcholine receptorInternal medicine
MeSH terms
VareniclineAnimalsBenzazepinesNeuronsOocytesQuinoxalinesReceptors, NicotinicXenopus laevisNicotinic AgonistsRatsalpha7 Nicotinic Acetylcholine Receptor
Funding
- University of Miami
- U.S. Food and Drug Administration
Citations
552
FWCI
11.00
field-weighted impact
References
26
Percentile
99%
vs. same field & year
Citations per year
Cited by
Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid
Neuropharmacology · 2006 · 533 citations
Systematic integration of biomedical knowledge prioritizes drugs for repurposing
eLife · 2017 · 579 citations
References
Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation
Journal of Medicinal Chemistry · 2005 · 930 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.